Skip Navigation

European Heart Journal 1995 16(3):348-353;
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MARQUES-VIDAL, P.
Right arrow Articles by CAMBIEN, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARQUES-VIDAL, P.
Right arrow Articles by CAMBIEN, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Medical treatment of myocardial infarction in France and Northern Ireland

Results from the ECTIM study

P. MARQUES-VIDAL*,, J.-P. CAMBOU*, A. EVANS{dagger}, D. ARVEILER{ddagger}, G. LUC§, A. BINGHAM|| and F. CAMBIEN

*MONICA-Toulouse INSERM U326 ORSMIP, C.H.U. Purpan, Toulouse, France
{dagger}MONICA Belfast, Department of Epidemiology and Public Health, The Queen's University of Belfast Belfast, U.K.
{ddagger}MONICA-Strasbourg, Laboratoire d'Epidémiologie et de Santé Publique Strasbourg, France
§Institut Pasteur de Lille Lille, France
||INSERM U258, HÔpital Broussais Paris, France
INSERM SC7, Paris, France

accepted 26 August 1994.

Correspondence Dr Pedro Marques-Vidal. MONICA-Toulouse. INSERM U326 C.H U Purpan. 31059 Toulouse Cedex. France

Abstract

As part of the ECTIM Study, the medical treatment given to male patients (25–64 years) 3 to 9 months after myocardial infarction (MI) were analysed in France and Northern Ireland. On univariate analysis, hypolipidaemic drugs, angiotensin-converting enzyme inhibitors and antiarrhythmic drugs were found to be prescribed more frequently in France, while beta-blockers were more common in Northern Ireland. No differences were found for diuretics, calcium channel blockers, antithrombotic and anti-anginal drugs, although the Northern Irish patients were mainly on antiplatelet drugs and nitrates, while the French patients received nitrates and non-nitrates, as well as oral anticoagulants and antiplatelet drugs in similar amounts. These differences remained after adjustment for personal history of diabetes, hyperlipidaemia, hypertension, and previous myocardial infarction, but the beta-blocker prescription was no longer significant. When the French centres were analysed, patients from Strasbourg were more frequently on oral anticoagulants and diuretics and less frequently on antiplatelet drugs, while patients from Toulouse had fewer anti-anginal drugs. Hence, although the current guidelines for secondary prevention of myocardial infarction are generally well applied in France and Northern Ireland, significant differences exist regarding the choice of the active drug.

Key Words: Medical prescriptions • France • Northern Ireland • myocardial infarction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HeartHome page
P Marques-Vidal, J-B Ruidavets, J-P Cambou, and J Ferrieres
Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993
Heart, August 1, 2000; 84(2): 171 - 175.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.